inforMED
MalfunctionLCP

TINA-QUANT HBALC GEN. 3

Received Jun 29, 2023 · Event occurred Jun 1, 2023

Report 1823260-2023-02120 · MDR key 17226344

Device

Generic name

Assay, Glycosylated Hemoglobin

Manufacturer

Roche Diagnostics

Model number

HBA1C TQ G3

Catalog number

05336163190

Lot number

ASKU

Product problems

  • High Test Results
  • High Test Results

Patient

Unknown

  • No Clinical Signs, Symptoms or Conditions
  • No Clinical Signs, Symptoms or Conditions

Narrative

Additional Manufacturer Narrative

THE SERVICE MAINTENANCE ACTIONS PERFORMED BY THE FSE RESOLVED THE ISSUE. NO FURTHER ISSUES WERE REPORTED AFTER THE SERVICE VISIT.

Additional Manufacturer Narrative

THE ANALYZER SERIAL NUMBER IS (B)(6). THE FIELD SERVICE ENGINEER (FSE) FOUND THAT THE SAMPLE LINE WAS DIRTY. THE FSE REPLACED THE SAMPLE PROBE AND CLEANED THE SAMPLE LINE. OPERATIONAL AND MECHANICAL CHECKS WERE PERFORMED SUCCESSFULLY. THE CUSTOMER PERFORMED QC SUCCESSFULLY. THE INVESTIGATION IS ONGOING.

Description of Event or Problem

THERE WAS AN ALLEGATION OF QUESTIONABLE A1C-2 TINA-QUANT HEMOGLOBIN A1C GEN.2 RESULTS FOR 4 PATIENT SAMPLES ON A COBAS 8000 COBAS C 502 MODULE. THE INITIAL RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY. THE CUSTOMER HAD BEEN HAVING PREVIOUS TEST ISSUES AND DECIDED TO REPEAT THE PATIENT SAMPLES. FOR PATIENT 1, THE INITIAL A1C RESULT WAS 8.6%. THE REPEAT RESULT WAS 5.2%. FOR PATIENT 2, THE INITIAL A1C RESULT WAS 9.1%. THE REPEAT RESULT WAS 6.39%. FOR PATIENT 3, THE INITIAL A1C RESULT WAS 9%. THE REPEAT RESULT WAS 6.33%. FOR PATIENT 4, THE INITIAL A1C RESULT WAS 8.5%. THE REPEAT RESULT WAS 5.7%. THE REPEAT RESULTS WERE DEEMED CORRECT.